Lithium Aspartate Not Effective for Neurologic Long COVID Fatigue

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, Oct. 15, 2024 -- Lithium aspartate is not effective for neurologic post-COVID-19 condition (PCC) symptoms of fatigue and cognitive dysfunction, according to a study published online Oct. 2 in JAMA Network Open.

Thomas Guttuso Jr., M.D., from the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo in Williamsville, New York, and colleagues conducted a randomized, placebo-controlled trial involving participants in a neurology clinic to examine the effects of lithium aspartate therapy on PCC fatigue and cognitive dysfunction. Fifty-two participants were randomly assigned to receive lithium aspartate 10 to 15 mg/day or identically appearing placebo for three weeks (26 patients in each group), followed by two weeks of open-label lithium aspartate 10 to 15 mg/day. The main outcome measures were the changes in sum of Fatigue Severity Scale-7 or Brain Fog Severity Scale scores.

The researchers observed no adverse events attributable to lithium therapy. No significant intergroup differences were seen for the primary outcome or any secondary outcomes, including changes from baseline in the scores of additional questionnaires. Three patients completed a subsequent dose-finding study; open-label lithium aspartate 40 to 45 mg/day versus 15 mg/day was associated with numerically greater reductions in fatigue and cognitive dysfunction scores.

"Another randomized controlled trial is required to assess the potential benefits of higher lithium dosages for treating neurologic PCC," the authors write.

One author disclosed ties to e3 Pharmaceuticals.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-16 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords